Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Redox biology"
DOI: 10.1016/j.redox.2021.101942
Abstract: Sorafenib is a first-line molecular-target drug for advanced hepatocellular carcinoma (HCC), but its clinical effects are still limited. In this study we identify Quiescin sulfhydryl oxidase 1 (QSOX1) acting as a cellular pro-oxidant, specifically in…
read more here.
Keywords:
hepatocellular carcinoma;
endosomal trafficking;
sorafenib induced;
sulfhydryl oxidase ... See more keywords
Photo by nci from unsplash
Sign Up to like & get
recommendations!
0
Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-82381-3
Abstract: The activated hepatic stellate cells (HSCs) are the major cells that secrete the ECM proteins and drive the pathogenesis of fibrosis in chronic liver disease. Targeting of HSCs by modulating their activation and proliferation has…
read more here.
Keywords:
vacuolation;
cell;
sorafenib induced;
cell death ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0271631
Abstract: Sorafenib is an oral multi-kinase receptor inhibitor that targets various signaling pathways. It is used as the first line of treatment in advanced hepatocellular and renal cell carcinomas. Sorafenib was reported to induce cardiotoxicity due…
read more here.
Keywords:
induced cardiotoxicity;
sorafenib induced;
hesperetin;
cardiotoxicity ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.22775
Abstract: Resminostat, a novel class I, IIb, and IV histone deacetylase inhibitor, was studied in advanced hepatocellular carcinoma (HCC) patients after relapse to sorafenib (SHELTER study). In this phase I/II clinical trial, combination of sorafenib and…
read more here.
Keywords:
hepatocellular carcinoma;
sorafenib induced;
hcc;
induced apoptosis ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.788667
Abstract: Sorafenib has attracted much attention as the first drug approved by the FDA for the treatment of advanced hepatocellular carcinoma (HCC). Because of the drug tolerance, the overall outcomes were far from satisfactory. Current studies…
read more here.
Keywords:
induced autophagy;
hsp90;
hepatocellular carcinoma;
sorafenib induced ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.904314
Abstract: Sorafenib is the unique recommended molecular-targeted drug for advanced hepatocellular carcinoma, but its clinical use is limited due to cardiotoxicity. As sorafenib is an efficient ferroptosis inducer, the pathogenesis of this compound to ferroptosis-mediated cardiotoxicity…
read more here.
Keywords:
induced cardiotoxicity;
sorafenib induced;
cardiotoxicity;
sorafenib ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms20164048
Abstract: Sorafenib is a multi-kinase inhibitor and one of the few systemic treatment options for patients with advanced hepatocellular carcinomas (HCCs). Resistance to sorafenib develops frequently and could be mediated by the nicotinamide adenine dinucleotide (NAD)-dependent…
read more here.
Keywords:
sirt1;
sorafenib induced;
treatment;
induced apoptosis ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Acta Biochimica et Biophysica Sinica"
DOI: 10.3724/abbs.2022166
Abstract: Ferroptosis, a newly defined and iron-dependent cell death, morphologically and biochemically differs from other cell deaths. Melanoma is a serious type of skin cancer, and the poor efficacy of current therapies causes a major increase…
read more here.
Keywords:
cell death;
ferroptosis melanoma;
melanoma;
sorafenib induced ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Indian Journal of Dermatology, Venereology and Leprology"
DOI: 10.4103/ijdvl.ijdvl_67_19
Abstract: Sir, A 60‐year‐old male with grade III hepatocellular carcinoma taking sorafenib 400 mg twice daily since 10 days was referred to the dermatology outpatient department for erosions and ulcerations on scrotum, penis, and frictional zones…
read more here.
Keywords:
foot skin;
scrotum penis;
grade iii;
dermatology ... See more keywords